First Trust Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,355,502
Closed -$24.2M – 181
2023
Q2
$24.2M Hold
2,355,502
– – 1.44% 18
2023
Q1
$23.8M Buy
+2,355,502
New +$23.7M 1.03% 19

First Trust Capital Management's DALS Position: Q3 2023 in Review

First Trust Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 2,355,502 shares — an estimated $24.2M sold.

First Trust Capital Management first reported a position in DALS in Q1 2023 and held it in 2 quarters. The position peaked at $24.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • First Trust Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • First Trust Capital Management sold 2,355,502 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $24.2M.
  • First Trust Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2023 and held it in 2 quarters.
  • First Trust Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $24.2M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on First Trust Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.